HM2026-06: A Randomized, Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Zilovertamab Vedotin(MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve

Project: Research project

Status	Active
Effective start/end date	3/27/26 → 3/31/36

Project Details